EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 161 filers reported holding EAGLE PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,022,083 | -9.3% | 191,635 | +11.8% | 0.01% | 0.0% |
| Q2 2023 | $3,332,618 | -47.2% | 171,431 | -22.9% | 0.01% | -50.0% |
| Q1 2023 | $6,310,339 | +43.3% | 222,430 | +47.7% | 0.01% | +25.0% |
| Q4 2022 | $4,402,856 | +89.0% | 150,628 | +70.8% | 0.01% | +100.0% |
| Q3 2022 | $2,329,000 | -74.8% | 88,172 | -57.6% | 0.00% | -73.3% |
| Q2 2022 | $9,248,000 | -25.8% | 208,169 | -17.4% | 0.02% | -6.2% |
| Q1 2022 | $12,470,000 | -11.0% | 251,979 | -8.5% | 0.02% | 0.0% |
| Q4 2021 | $14,018,000 | – | 275,305 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 94,922 | $4,063,000 | 1.33% |
| Smith, Graham & Co., Investment Advisors, LP | 277,572 | $11,880,000 | 1.05% |
| Krensavage Asset Management, LLC | 70,804 | $3,030,000 | 1.03% |
| BRANDES INVESTMENT PARTNERS, LP | 716,873 | $30,682,000 | 0.68% |
| GLOBEFLEX CAPITAL L P | 42,357 | $1,813,000 | 0.33% |
| Zebra Capital Management LLC | 6,472 | $277,000 | 0.32% |
| Capital Impact Advisors, LLC | 19,276 | $825,000 | 0.27% |
| Hein Park Capital Management LP | 31,977 | $1,369,000 | 0.26% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 195,340 | $8,361,000 | 0.25% |
| Stanley-Laman Group, Ltd. | 24,000 | $1,027,000 | 0.15% |